Reports

The global In-Vitro Diagnostics market was valued at 79319 million in 2025 and is projected to reach US$ 106820 million by 2032, at a CAGR of 4.5% during the forecast period.

The global Total Parenteral Nutrition (TPN) Solution market was valued at 3835 million in 2025 and is projected to reach US$ 6103 million by 2032, at a CAGR of 6.9% during the forecast period.

The global Peripheral Parenteral Nutrition (PPN) market was valued at 1141 million in 2025 and is projected to reach US$ 1741 million by 2032, at a CAGR of 6.3% during the forecast period.

The global Therapeutic Intensive Care market was valued at 52964 million in 2025 and is projected to reach US$ 83169 million by 2032, at a CAGR of 6.6% during the forecast period.

The global Medical Device Cytotoxicity Testing market was valued at 157 million in 2025 and is projected to reach US$ 271 million by 2032, at a CAGR of 8.2% during the forecast period.

The global iPSC-Derived Retinal Pigment Epithelial Cells market was valued at 35.61 million in 2025 and is projected to reach US$ 129 million by 2032, at a CAGR of 20.1% during the forecast period.

The global IPSC-Derived Pancreatic Beta-Like Cells market was valued at 45.66 million in 2025 and is projected to reach US$ 1175 million by 2032, at a CAGR of 59.6% during the forecast period.

The global iPSC-Derived Ovarian Support Cell Technology market was valued at 13.70 million in 2025 and is projected to reach US$ 76.47 million by 2032, at a CAGR of 20.0% during the forecast period.

The global Tumor Organoid Drug Sensitivity Testing market was valued at 221 million in 2025 and is projected to reach US$ 781 million by 2032, at a CAGR of 20.0% during the forecast period.

The global Trichomonas Rapid Testing market was valued at 443 million in 2025 and is projected to reach US$ 647 million by 2032, at a CAGR of 5.6% during the forecast period.